TargetMol

Lidocaine N-ethyl bromide

Product Code:
 
TAR-T8341
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
 

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T8341-5mg5mg£124.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8341-1mL1 mL * 10 mM (in DMSO)£139.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8341-10mg10mg£151.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8341-25mg25mg£215.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8341-50mg50mg£288.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T8341-100mg100mg£397.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Lidocaine N-ethyl bromide is a blocker of non-membrane-permeable,and Inhibits Acid-Induced Activation of Esophageal Nociceptive C Fiber Neurons.
CAS:
21306-56-9
Formula:
C16H27BrN2O
Molecular Weight:
343.31
Purity:
0.98
SMILES:
[Br-].CC[N+](CC)(CC)CC(=O)Nc1c(C)cccc1C

References

Laffon M , Jayr C , Barbry P , et al. Lidocaine Induces a Reversible Decrease in Alveolar Epithelial Fluid Clearance in Rats[J]. Anesthesiology, 2002, 96(2):392-399. Hu Y , Yu X , Yu S . QX-314 inhibits acid-induced activation of esophageal nociceptive C fiber neurons[J]. Neurogastroenterology & Motility, 2019.